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A sthma is an airway inflammatory disease charac-terised by recurrent attacks of breathlessness and 
wheezing, and is caused by hypersensitivity of nerve 
endings in the bronchial tree of the lungs.1Asthma af-
fects 325 million people around the globe; one in 250 
deaths worldwide is attributed to this condition.2 
Most asthma-related deaths are preventable with effec-
tive treatment. The disease is a growing problem in Af-
rica, and prevalence rates range from 9% to 20%.2 In 
Sudan, an East African country, asthma is the third 
major cause of hospitalisation after pneumonia and 
malaria, and public hospitals have seen a striking in-
crease in the number of emergency visits by asthma 
patients, from 20 000 in 1998 to 106 000 in 2004 (a 
more than five-fold increase).3
Since 2006, the Epidemiological Laboratory (EPI-
LAB), a non-governmental, non-profit research centre 
based in Khartoum, Sudan, has been implementing an 
asthma control programme in Khartoum and Gazeera 
States in collaboration with the Ministry of Health, 
the World Health Organization (WHO) and the Inter-
national Union Against Tuberculosis and Lung Disease 
(The Union).4
Asthma severity is judged by the degree of impair-
ment of airflow through the airways, assessed by mea-
suring the peak expiratory flow (PEF), i.e., the maxi-
mum amount of air that can be expelled from the 
lung per minute. PEF can be measured in any clinical 
setting by using a simple hand-held device, called a 
peak flow meter. One of the cornerstones of the assess-
ment of asthma severity and disease management is 
the correct and complete recording of patient data (in-
cluding PEF) on patient master cards.5 Complete re-
cording of such data is also vital for quarterly cohort 
reporting and for evaluating overall programme 
performance.5
No formal assessment of asthma patient monitor-
ing has been made at programme level in Sudan. An-
ecdotal evidence suggests that patient cards are not 
being filled out correctly, and this has patient and pro-
grammatic implications.
We assessed 1) the completeness of filling out treat-
ment cards and 2) the accuracy of PEF calculations for 
confirming asthma diagnosis and grading severity in 
four public health centres offering asthma treatment 
in Gazeera State, Sudan.
METHODS
Study design
A cross-sectional audit of asthma treatment cards.
Study setting
Sudan is a low-income country in East Africa with an 
estimated population of 27 million. Gazeera State in 
central Sudan covers an area of 27 549 million km2, 
and has a population of 3.5 million. The state is di-
vided into seven districts, with one teaching hospital, 
seven district hospitals and 45 health centres. Each of 
the district hospitals has a health centre that offers 
services dedicated to asthma, supported by EPI-LAB. 
The present study involved four EPI-LAB asthma cen-
tres located at the four largest district hospitals, Kam-
leen, Hashesa, Mangel and Madani.
Study population
All asthma treatment cards for the period June 2006 to 
December 2012 were included in the study, which was 
conducted between March and December 2013.
Asthma EPI-LAB centres
The EPI-LAB centres are staffed by medical officers and 
general practitioners who provide asthma care accord-
ing to The Union asthma guidelines.6 Briefly, patients 
who arrive at an asthma health centre are registered 
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Setting: Four public district hospitals offering asthma 
treatment in Gazeera State, Sudan. Incomplete recording 
of patient data directly affects the quality of asthma care 
and the evaluation of asthma management programmes.
Objective: To assess the completeness of filling out of 
treatment cards and accuracy of calculating peak expira-
tory flow (PEF) for confirming diagnosis and grading se-
verity of asthma.
Design: Cross-sectional audit of asthma treatment cards 
from asthma centres, 2006–2012.
Results: Of 959 patient cards assessed, completeness 
ranged from 47% to 98%. Six of 13 variables had an un-
satisfactory grade of completeness (80% complete). 
Calculated PEF was indicated in 885 (92%) cards, but 
was correct in only 609 (69%). PEF variability was re-
corded in 835 (87%) cards, but was correctly calculated 
in 442 (53%). A scheduled follow-up visit was attended 
by only 359 (37%) patients, indicating 63% loss to fol-
low-up. Contact telephone numbers were missing from 
453 (47%) cards.
Conclusion: This is the first study in Africa to assess the 
data completeness and integrity of asthma patient cards, 
identifying important shortcomings. This affects quality 
of management of asthma patients and programme eval-
uation. Steps to rectify this situation are urgently needed.
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and given an asthma patient card before receiving any 
treatment. The asthma cards are filled out directly by 
the attending clinician after the patient has undergone 
clinical assessment. The cards are kept in lockable fil-
ing cabinets at each centre and are readily accessible. 
There are no dedicated nurses in the centres.
Clinical status and PEF are used to assess lung 
function as shown in Figure 1. Management is then 
tailored according to disease severity. Patients are re-
quired to return for follow-up visits at least once ev-
ery 3 months. At each follow-up, asthma severity is 
re-assessed and treatment is adjusted accordingly. All 
health staff involved in asthma control in the four 
district hospitals have undergone training in various 
aspects of asthma management. Quarterly visits and 
refresher training are provided by both EPI-LAB and 
the Ministry of Health. There is a dedicated EPI-LAB 
asthma coordinator and a Gazeera State asthma coor-
dinator who collaborate to ensure regular 
supervision.
Completeness of treatment cards
Completeness of data was verified for the following in-
dicators from the patient card (Figures 1 and 2): age, 
sex (used to calculate predicted PEF), contact details 
(patient, neighbour, next of kin, telephone numbers), 
predicted PEF, PEF measured before and after broncho-
dilator use, the calculated PEF percentage, confirma-
tion of diagnosis and severity and treatment prescribed 
at the initial visit. For the follow-up visits, data col-
lected included whether the patient had attended the 
visit and data on severity, treatment prescribed and 
emergency visits/hospitalisation.
Accuracy of PEF calculations for grading severity 
and confirming diagnosis
The highest value (obtained before and after broncho-
dilator use) in relation to the predicted PEF (the PEF of 
a given person in relation to age and sex), termed the 
‘best PEF’, was used to determine asthma severity and 
the line of management. PEF variability was used to 
confirm asthma diagnosis. The method used to calcu-
late this is shown in Figure 1.
Based on the PEF measures entered on the treat-
ment cards by the health care provider, we re-calcu-
lated the best PEF (used to grade severity) and PEF vari-
ability (required to confirm the asthma diagnosis) to 
evaluate the accuracy of the PEF calculations.
Data collection and analysis
Data were collected from the asthma treatment cards 
and electronically captured using EpiData software 
(version 3.1, EpiData Association, Odense, Denmark). 
Data entry was validated by comparing data from 10% 
of the patient cards that have been randomly selected. 
The completeness of data was graded according to the 
following pre-defined criteria: good (filled out in 
95% of cases); satisfactory (80–95% complete); unsat-
isfactory (80% complete). Correctness of PEF calcula-
tion was graded using the same cut-offs. These cut-offs 
were set in-house as there is currently no reference 
standard. Descriptive analysis was performed by calcu-
lating frequencies and percentages.
Ethics approval
Ethics approval was obtained from the EPI-LAB Ethics 
Committee of the University of Science and Technol-
ogy, Khartoum, Sudan. This study met the Médecins 
Sans Frontières (Geneva, Switzerland) Ethics Review 
Board-approved criteria for analysis of routinely col-
lected programme data. It also satisfied the require-
ments of the Ethics Advisory Group of The Union, 
Paris, France.
RESULTS
During the study period, a total of 959 registered 
asthma patient cards were assessed for completeness 
(Table 1). The completeness of recording for the nine 
variables assessed at the first patient visit ranged from 
47% to 98%. Three of the nine variables had an unsat-
isfactory grade (80%) of completeness. Although un-
recorded information was the main problem, 99 (10%) 
cards had at least one variable with unreadable infor-
mation. Only 453 (47%) treatment cards had a tele-
phone contact number. The PEF calculated was indi-
cated on 885 (92%) patient cards and was graded as 
satisfactory. However, the calculation was correct in 
only 609 (69%) cases. Errors in calculation led to fail-
ure to diagnose 15 patients as severe asthma 
(underdiagnosis).
Similarly, although PEF variability was indicated 
satisfactorily in 835 (87%) patient cards, the calcula-
tion was correct in only 442 (53%). Table 2 shows the 
completeness of follow-up data. A scheduled follow-up 
visit was attended by only 359 (37%) patients, indicat-
ing 63% loss to follow up. The four variables assessed 
for completeness of recording at the follow-up visit 
ranged from 5% to 98%. Three (75%) of the four vari-
ables had an unsatisfactory grade of completeness. Un-
readable notes were common, with 299 (83%) cards 
having at least one variable with unreadable 
information.
DISCUSSION
This is the first study in Africa to assess the integrity of 
asthma-related data recorded on patient cards. In four 
district hospitals in Sudan, about 6/13 variables on the 
patient cards were deemed unsatisfactory in terms of 
data completeness. In addition, correctness of PEF cal-
culations was only 53% for confirming an asthma di-
agnosis and 69% for ‘best PEF’, which is vital for judg-
ing disease severity and the line of management. 
Incomplete data recording directly affects the quality 
of patient care and and seriously compromises the 
ability to evaluate programme performance. It thus 
has important implications.
The strengths of this study are that the study sam-
ple was large, the majority of the variables included in 
the patient card were assessed for completeness, and 
data came from district hospital settings and thus 
likely reflected ground reality. Data entry was per-
formed by trained data entry staff and validated. In ad-
dition, we followed STROBE (Strengthening the Re-
porting of Observational Studies in Epidemiology) 
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guidelines for observational studies, including ethics.7,8 A study 
limitation is that we did not specifically investigate the possible 
reasons for incomplete data recording or assess for varying trends 
over the approximately 6-year study period. Furthermore, the cut-
offs used to classify data completeness were set in-house, as there 
is no reference standard. The standards we have used might thus 
be deemed too high or low.
A number of study findings merit discussion. First, 6/10 pa-
tients didn’t return for the scheduled follow-up visit at month 3 
and were lost to follow-up. The fact that patient contact informa-
tion was recorded in only 47% of patient cards is thus of opera-
tional concern, as this hampers attempts to trace such patients. 
The importance of recording contact information should be em-
phasised to patient registration clerks. Another study from Sudan, 
focusing on severe cases, revealed a loss to follow-up of 56%,9 and 
another from Benin reported 36% loss to follow-up.10 These find-
ings suggest the need for more effective tracing strategies for 
asthma patients on follow-up.
Second, an issue of serious concern is the high error rate of PEF 
calculations. Anecdotal evidence from site visits revealed that 
none of the centres had functional calculators. This may have led 
to busy clinicians resorting to manual calculations, which are 
more prone to error. A possible solution is to introduce real-time 
computer or touch-screen electronic patient cards, as is currently 
being used for chronic disease management in health facilities in 
Malawi11,12 and Jordan.13 PEF calculations could then be auto-
mated, which would limit errors. Electronic patient cards (EPC) 
would also address the problem of illegible writing, a common 
problem identified in this study. The EPC can be preset to ensure 
compulsory and complete data entry. Such a system can also al-
low bar coding on patient identity cards, which would provide 
the added advantage of allowing quick access to individual pa-
tient information at any of the asthma centres to which a regis-
tered patient may present. Specific training to improve the under-
standing and recording of PEF calculations is required.
Third, only 7/10 patient cards recorded whether or not corti-
costeroid treatment had been prescribed. Such information is vi-
tal to be able to project drug consumption and avoid stock rup-
tures. This is particularly relevant for corticosteroids, which are 
essential for those with severe asthma in whom morbidity and 
mortality are likely to be highest.
Finally the asthma centres face staffing shortages, with only 
one attending general practitioner and no dedicated nurses or 
support staff. Even the general practitioners, although theoreti-
cally dedicated to asthma centres, cover several additional clinical 
responsibilities in various hospital wards. The storage infrastruc-
ture for patient cards also varied between centres; this may affect 
organisation and access to cards. Anecdotal evidence suggests that 
there are delays associated with finding cards before patients can 
be seen by clinicians. Undue delays that add to patient waiting 
times may affect the acceptability of a centre and influence loss to 
follow-up rates. This merits specific evaluation. The various short-
comings highlight the need for rigorous quarterly supervision 
and targeted training, with particular attention to data quality.
In conclusion, we have identified important shortcomings in 
the integrity and completeness of recorded asthma patient data in 
Sudan. This has a bearing on the quality of asthma patient man-
agement as well as on the evaluation of programme performance; 
steps to rectify this situation are urgently needed.
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TABLE 1 Completeness of baseline key information on asthma 
treatment cards, Gazeera State, Sudan, 2006–2012 (n = 959)
Variable
Recorded
n (%)
Not recorded/
unreadable
n (%)
Completeness  
of data*
Age 943 (98) 16 (2) Good
Sex 918 (96) 41 (4) Good
Telephone number 452 (47) 507 (53) Unsatisfactory
PEF measurements† 914 (95) 45 (5) Good
Calculated PEF 885 (92) 74 (7) Good
Severity grade 823 (86) 136 (14) Satisfactory
Diagnostic confirmation 738 (77) 221 (23) Unsatisfactory
PEF variability 835 (87) 124 (13) Satisfactory
Corticosteroid treatment 689 (72) 270 (28) Unsatisfactory
* Good: recorded in 95%; satisfactory: 80–95%; unsatisfactory: 80%; same cate-
gories for correctness of calculation.
† Predicted PEF, PEF before and after bronchodilator use.
PEF = peak expiratory flow.
TABLE 2 Completeness of key follow-up information on asthma 
treatment cards, Gazeera State, Sudan, 2006–2012 (n = 359)
Variable
Recorded
n (%)
Not recorded/
unreadable
n (%)
Completeness  
of data*
Severity of symptoms 153 (43) 206 (57)† Unsatisfactory
PEF values 353 (98) 6 (2) Good
Corticosteroid treatment 234 (64) 125 (36)‡ Unsatisfactory
Unplanned visits 17 (5) 342 (95)§ Unsatisfactory
* Good: recorded in 95%; satisfactory: 80–95%; unsatisfactory: 80%; same cate-
gories for correctness of calculation.
† Unreadable for 172.
‡ Unreadable for 80.
§ Unreadable for 286.
PEF = peak expiratory flow.
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Contexte  :  Quatre hôpitaux publics de district offrant un traitement 
de l’asthme dans l’état de Gazeera, Soudan. La saisie incomplète 
des données relatives aux patients affecte directement la qualité des 
soins de l’asthme et l’évaluation des programmes de prise en 
charge.
Objectif  :  Evaluer l’exhaustivité du remplissage des cartes de 
traitement et l’exactitude des calculs de débit expiratoire de pointe 
(DEP) pour la confirmation du diagnostic et l’estimation du degré de 
gravité de l’asthme.
Schéma  :  Audit transversal des cartes de traitement de patients 
asthmatiques dans les centres de prise en charge, de 2006 à 2012.
Résultats  :  Sur 959 cartes de patients évaluées, l’exhaustivité variait 
de 47% à 98%. Six variables sur 13 n’étaient pas correctement 
relevées (80% d’exhaustivité). Le DEP calculé était indiqué sur 885 
(92%) cartes, mais n’était juste que sur 609 (69%) cartes. La 
variabilité du DEP était notée sur 835 (87%) cartes mais était 
correctement calculée sur seulement 442 (53%). Seuls 359 (37%) 
patients ont assisté à leur consultation de contrôle, ce qui signifie que 
63% ont été perdus de vue. Il manquait un numéro de téléphone de 
contact sur 453 (47%) cartes.
Conclusion  :  Cette première étude africaine d’évaluation de 
l’exhaustivité des données et de l’intégrité des cartes de traitement 
des patients asthmatiques a identifié des lacunes importantes. 
Celles-ci affectent la qualité de la prise en charge des patients 
asthmatiques et l’évaluation des programmes. Il est urgent de 
prendre des mesures afin de rectifier ces problèmes.
Marco de referencia: Cuatro hospitales distritales del sector público 
que suministran tratamiento del asma en el estado de Gazeera en 
Sudán. El registro incompleto de los datos de los pacientes 
menoscaba directamente la calidad del tratamiento del asma y la 
evaluación de los programas de atención.
Objetivo: Evaluar el carácter integral del llenado de las tarjetas de 
tratamiento y la exactitud del cálculo del flujo espiratorio máximo 
(FEM) al confirmar el diagnóstico de asma y evaluar su gravedad.
Método: Se examinaron las tarjetas de tratamiento de los pacientes 
asmáticos en los centros especializados del 2006 al 2012.
Resultados: De las 959 tarjetas de tratamiento examinadas, entre 
47% y 98% contaban con la información completa de los pacientes. 
Seis de las 13 variables presentaban un grado de integridad deficiente 
(menos de 80% de compleción). En 885 tarjetas se había consignado 
el FEM (92%), pero el cálculo era correcto en solo 609 casos (69%). 
La variabilidad del FEM se registró en 835 tarjetas (87%), pero su 
cálculo fue correcto solo en 442 (53%). Solo 359 pacientes (37%) 
acudieron a una cita de control programada, lo cual corresponde a 
63% de pérdidas durante el seguimiento. En 453 tarjetas (47%) 
faltaba un número telefónico de contacto.
Conclusión: El presente fue el primer estudio de evaluación de la 
compleción y la integridad de los datos de las tarjetas de tratamiento 
del asma en África y reveló carencias considerables. Esta situación 
deteriora la calidad del tratamiento de los pacientes con asma y la 
evaluación de los programas. Es necesario adoptar con urgencia 
medidas encaminadas rectificar estas deficiencias.
